Strategic BioSolutions provides custom polyclonal and monoclonal antibody production and purification services including antisera production, hybridoma development, ascites production, in-vitro production, purification, conjugation, fragmentation, bioprocessing, and contract assay development. Strategic BioSolutions also supplies antibodies and calibrator products for the clinical diagnostic and research markets. Products include antibodies to human serum proteins, cardiac markers, cancer markers, human hormones, and infectious agents.